Mass Spectrometry Market - 7.4% CAGR to 2022 Led by North America

The global mass spectrometry market is forecast to reach $5.27 billion in 2022 from $3.68 billion in 2017 at a CAGR of 7.4% during (2017-2022) driven by the growth of the pharmaceutical and biotechnology industry, technological advancements in mass spectrometry, the growing use of mass spectrometry in emerging markets and the rising potential for the application of high-resolution mass spectrometry in healthcare.

PUNE, India, Nov. 9, 2017 /PRNewswire-iReach/ -- North America is expected to register the highest CAGR in the global mass spectrometry market during the forecast period of 2017-2022. Factors such as growing bio pharmaceutical and biotechnology research & development and availability of funding for innovation-based research coupled with the boost in the US shale oil and gas production are expected to drive market growth during the forecast period.

Browse 109 Market Data Tables and 36 Figures spread through 176 Pages and in-depth TOC on "Mass Spectrometry Market by Platform (Hybrid mass spectrometry (Triple Quadrupole, QTOF & FTMS), Single mass spectrometry (Quadrupole, TOF & Ion Trap)), Application (Pharmaceuticals, Biotechnology, Environmental testing) - Global Forecast to 2022

The major players in the mass spectrometry market include Sciex (Subsidiary of Danaher) (US), Agilent Technologies (US), Waters Corporation (US), Thermo Fisher Scientific (US), PerkinElmer (US), and Shimadzu Corporation (Japan).

Based on application, the mass spectrometry market is segmented into pharmaceutical applications, biotech applications, environmental testing, food and beverage testing, petrochemical applications, and other applications. During the forecast period, the pharmaceutical application is expected to grow at the highest CAGR. This growth is mainly due to the growing importance of mass spectrometry in various stages of drug development and increasing R&D in pharmaceutical industries.

Inquire for Discount on "Mass Spectrometry Market - Global Forecast to 2022" research report at

The report analyzes the mass spectrometry market and aims at estimating the market size and the future growth potential of this market based on various segments such as type of mass spectrometry on the basis of platform, application, and region. The report also includes an in-depth regulatory analysis for various regions across the globe and competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.

Break of primary participants was as mentioned below:

  • By Company Type: Tier 1 - 52%, Tier 2 - 30%, and Tier 3 - 18%
  • By Designation: C-level - 45%, Director Level - 30%, Others - 25%
  • By Region: North America - 36%, Europe - 24%, Asia-Pacific - 29%, RoW - 11%

Make an Inquiry on Mass Spectrometry Marketby Platform (Hybrid mass spectrometry (Triple Quadrupole, QTOF & FTMS), Single mass spectrometry (Quadrupole, TOF & Ion Trap)), Application (Pharmaceuticals, Biotechnology, Environmental testing) - Global Forecast to 2022 research report at .

By technology, the hybrid mass spectrometry segment accounted for the largest share of the market in 2017. The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a greater share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies.

The European mass spectrometry market is driven by the availability of funds for research, growing cosmetics industry in Germany, growing food safety concerns and increased investments for pharmaceuticals in the UK, favorable scenario of biotechnology and pharmaceutical industry in Italy, company's expansion in France and strong food and beverage industry in Spain.

Another research titled Metabolomics Market Forecast to 2021 says, the global metabolomics market is projected to reach $2.39 billion by 2021, at a CAGR of 14.6% during the forecast period of 2016 to 2021. In 2015, North America commanded the largest share of the metabolomics market, followed by Europe. In 2015, the biomarker discovery segment accounted for the largest share of the global metabolomics market. Companies such as Agilent Technologies, Inc. (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Shimadzu Corporation (Japan), Waters Corporation (U.S.) Bio-Rad Laboratories (U.S.), Biocrates Life Sciences AG (Austria), Human Metabolome Technologies Inc. (Japan), LECO Corporation (U.S.), Metabolon Inc. (U.S.) have been profiled in this 286 pages research report available at .

About Us: is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Connect with Us:

G+ / Google Plus:



RSS / Feeds:

Media Contact: Hrishikesh Patwardhan, RnR Market Research, +1-888-391-5441,

News distributed by PR Newswire iReach:


SOURCE RnR Market Research



Biotechnology, Health Care & Hospitals, Environmental Products & Services, Surveys, Polls and Research

Need Help